On September 22, 2024, Synex Medical announced it raised $21.8 million in an oversubscribed Series A financing round. This round saw participation from existing investors including Accomplice, Radical Ventures, Naval Ravikant and new investors including Khosla Ventures, Fundomo and Aravind Srinivas. The company plans on utilizing the funding towards its vision of predictive medicine.
Synex Medical develops a health monitoring technology intended to make predictive health a reality by providing accurate and non-invasive monitoring at the molecular level.
Osler, Hoskin & Harcourt LLP advised Synex Medical with a team consisting of Chad Bayne, Gary Marshall, Ferial Fekri and Handi Xu (Emerging and High Growth Companies).
Key Contacts
Team
Partner, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
Associate, Emerging and High Growth Companies, Toronto
